Spots Global Cancer Trial Database for breast epithelial hyperplasia
Every month we try and update this database with for breast epithelial hyperplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Protocol for Women at Increased Risk of Developing Breast Cancer | NCT00291096 | Breast Cancer | 30 Years - 65 Years | University of Kansas Medical Center | ||
Protocol for Women at Increased Risk of Developing Breast Cancer | NCT00291096 | Breast Cancer | 30 Years - 65 Years | University of Kansas Medical Center | ||
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | NCT00291122 | Breast Cancer | celecoxib 400 m... | 18 Years - | University of Kansas Medical Center | |
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | NCT00291122 | Breast Cancer | celecoxib 400 m... | 18 Years - | University of Kansas Medical Center | |
An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg | NCT00291109 | Breast Cancer | letrozole 2.5 m... | 18 Years - | University of Kansas Medical Center | |
Protocol for Women at Increased Risk of Developing Breast Cancer | NCT00291694 | Breast Cancer | celecoxib placebo | 18 Years - | University of Kansas Medical Center | |
Protocol for Women at Increased Risk of Developing Breast Cancer | NCT00291135 | Breast Cancer | letrozole | 18 Years - | University of Kansas Medical Center | |
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer | NCT00291083 | Breast Cancer | 18 Years - | University of Kansas Medical Center | ||
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D | NCT01166763 | Breast Cancer | vitamin D3 | - 55 Years | University of Kansas Medical Center | |
Protocol for Women at Increased Risk of Developing Breast Cancer | NCT00291135 | Breast Cancer | letrozole | 18 Years - | University of Kansas Medical Center |